AmeriSource Expects Post-Merger Market Share Of 33% To Pass FTC Review
This article was originally published in The Tan Sheet
Executive Summary
AmeriSource and Bergen Brunswig predict the Federal Trade Commission will accept their combined 33% market share in the drug wholesaling sector without initiating an antitrust challenge.